CO2 Solutions Announces Notice of Allowance for Danish Intellectual Property


QUEBEC CITY, Nov. 26, 2015 /CNW/ - CO2 Solutions Inc. (or the "Corporation") (TSX-V: CST), the leader in the field of enzyme-enabled carbon capture technology, today announced it has received a notice of allowance for Danish Utility Model (intellectual property rights) N° BA202400177 - SYSTEM FOR CO2 CAPTURE USING PACKED REACTOR AND ABSORPTION MIXTURE WITH MICRO-PARTICLES INCLUDING BIOCATALYSTS - from the Danish Patent Office. 

The utility model will add even more depth to CO2 Solutions' extensive intellectual property portfolio, providing broad coverage for enzyme-accelerated processes for carbon capture.  CO2 Solutions believes this utility model could have significant value relative to one or more CO2 capture projects currently underway in Denmark that the Corporation believes may be infringing on the CO2 Solutions proprietary technology, including operations covered by this utility model.

The positive decision by the Danish Patent Office is all the more notable given that a leading European biotech company filed numerous documents and arguments against the pending CO2 Solutions application. Obtaining the allowance despite significant opposition further illustrates the strength and value of CO2 Solutions' intellectual property surrounding its innovative technologies. In addition, CO2 Solutions has numerous other patents/utility model pending in Denmark and Europe.

"This is a clear validation of the robustness of our patent portfolio, the competence of our IP team, and the uniqueness of our technology" stated Evan Price, President and Chief Executive Officer of CO2 Solutions. "With this utility model to be issued, we have added yet another element to our strong intellectual property portfolio, which we believe effectively covers the viable routes to commercialization of carbonic anhydrase enzyme-based systems for the capture of CO2, presenting more barriers to entry in this space. Our competitors should have no doubt that we will defend our IP vigorously whenever and wherever necessary."

About CO2 Solutions Inc.
CO2 Solutions is an innovator in the field of enzyme-enabled carbon capture and has been actively working to develop and commercialize the technology for stationary sources of carbon pollution.  CO2 Solutions' technology lowers the cost barrier to Carbon Capture, Sequestration and Utilization (CCSU), positioning it as a viable CO2 mitigation tool, as well as enabling industry to derive profitable new products from these emissions.  CO2 Solutions has built an extensive patent portfolio covering the use of carbonic anhydrase, or analogues thereof, for the efficient post-combustion capture of carbon dioxide with lowenergy aqueous solvents.  Further information can be found at

CO2 Solutions Forward-looking Statements
Certain statements in this news release may be forward-looking. These statements relate to future events or CO2 Solutions' future economic performance and reflect the current assumptions and expectations of management. Certain unknown factors may affect the events, economic performance and results of operation described herein. CO2 Solutions undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE CO2 Solutions Inc.

For further information: Investor Relations and Media Contact: CO2 Solutions: Thom Skinner, 418-842-3456, ext. 223,,; or NATIONAL Equicom, Marc Lakmaaker, 416-848-1397,


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890